HNF4A and hepatocellular carcinoma: As identified lipid-metabolism related lncRNA, our results from in vitro and in vivo experiments suggested that a potential treatment regimen for patients with HCC could involve combining sorafenib treatment with HNF4A-AS1 overexpression and a PUFA-rich diet.